wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38755707-2DB96814-9669-4FC2-9A4E-C989ED3A20C2
Q38755707-2DB96814-9669-4FC2-9A4E-C989ED3A20C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38755707-2DB96814-9669-4FC2-9A4E-C989ED3A20C2
Targeting BAFF and APRIL in systemic lupus erythematosus and other antibody-associated diseases.
P2860
Q38755707-2DB96814-9669-4FC2-9A4E-C989ED3A20C2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38755707-2DB96814-9669-4FC2-9A4E-C989ED3A20C2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
da1fce8880cf6304bcb131d9579f42a016801467
P2860
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus